GAS5 and neoplasm: Similarly, the tumor suppressor lncRNA GAS5 was shown to target Wnt/β-catenin signaling and attenuate ABCB-1-mediated adriamycin resistance via miR-221-3p/Dickkopf-related protein 2 (DKK2) pathway regulation [232].